215 related articles for article (PubMed ID: 20669972)
1. Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.
Mwakwari SC; Guerrant W; Patil V; Khan SI; Tekwani BL; Gurard-Levin ZA; Mrksich M; Oyelere AK
J Med Chem; 2010 Aug; 53(16):6100-11. PubMed ID: 20669972
[TBL] [Abstract][Full Text] [Related]
2. The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.
Sodji Q; Patil V; Jain S; Kornacki JR; Mrksich M; Tekwani BL; Oyelere AK
Bioorg Med Chem Lett; 2014 Oct; 24(20):4826-30. PubMed ID: 25240614
[TBL] [Abstract][Full Text] [Related]
3. A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum.
Chen Y; Lopez-Sanchez M; Savoy DN; Billadeau DD; Dow GS; Kozikowski AP
J Med Chem; 2008 Jun; 51(12):3437-48. PubMed ID: 18494463
[TBL] [Abstract][Full Text] [Related]
4. Discovery of a potent histone deacetylase (HDAC) 3/6 selective dual inhibitor.
Soumyanarayanan U; Ramanujulu PM; Mustafa N; Haider S; Fang Nee AH; Tong JX; Tan KSW; Chng WJ; Dymock BW
Eur J Med Chem; 2019 Dec; 184():111755. PubMed ID: 31627059
[TBL] [Abstract][Full Text] [Related]
5. Macrocyclic histone deacetylase inhibitors.
Mwakwari SC; Patil V; Guerrant W; Oyelere AK
Curr Top Med Chem; 2010; 10(14):1423-40. PubMed ID: 20536416
[TBL] [Abstract][Full Text] [Related]
6. Non-peptide macrocyclic histone deacetylase inhibitors.
Oyelere AK; Chen PC; Guerrant W; Mwakwari SC; Hood R; Zhang Y; Fan Y
J Med Chem; 2009 Jan; 52(2):456-68. PubMed ID: 19093884
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors.
Hansen FK; Skinner-Adams TS; Duffy S; Marek L; Sumanadasa SD; Kuna K; Held J; Avery VM; Andrews KT; Kurz T
ChemMedChem; 2014 Mar; 9(3):665-70. PubMed ID: 24497437
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Novel Anti-Plasmodial Histone Deacetylase Inhibitors Containing an Alkoxyamide Connecting Unit.
Alves Avelar LA; Held J; Engel JA; Sureechatchaiyan P; Hansen FK; Hamacher A; Kassack MU; Mordmüller B; Andrews KT; Kurz T
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28317157
[TBL] [Abstract][Full Text] [Related]
9. Discovery of class I histone deacetylase inhibitors based on romidpesin with promising selectivity for cancer cells.
Zhang K; Yao Y; Tu Z; Liao C; Wang Z; Qiu Y; Chen D; Hamilton DJ; Li Z; Jiang S
Future Med Chem; 2020 Feb; 12(4):311-323. PubMed ID: 31782319
[No Abstract] [Full Text] [Related]
10. A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.
Tapadar S; Fathi S; Raji I; Omesiete W; Kornacki JR; Mwakwari SC; Miyata M; Mitsutake K; Li JD; Mrksich M; Oyelere AK
Bioorg Med Chem; 2015 Dec; 23(24):7543-64. PubMed ID: 26585275
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.
Patil V; Guerrant W; Chen PC; Gryder B; Benicewicz DB; Khan SI; Tekwani BL; Oyelere AK
Bioorg Med Chem; 2010 Jan; 18(1):415-25. PubMed ID: 19914074
[TBL] [Abstract][Full Text] [Related]
12. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages.
Hansen FK; Sumanadasa SD; Stenzel K; Duffy S; Meister S; Marek L; Schmetter R; Kuna K; Hamacher A; Mordmüller B; Kassack MU; Winzeler EA; Avery VM; Andrews KT; Kurz T
Eur J Med Chem; 2014 Jul; 82():204-13. PubMed ID: 24904967
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Investigation of Therapeutic Potential of Isoform-Specific HDAC8 Inhibitors for the Treatment of Cutaneous T Cell Lymphoma.
Umamaheswari A; Puratchikody A; Hari N
Anticancer Agents Med Chem; 2019; 19(7):916-934. PubMed ID: 30836926
[TBL] [Abstract][Full Text] [Related]
14. Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity.
Wu B; Fathi S; Mortley S; Mohiuddin M; Jang YC; Oyelere AK
Bioorg Med Chem; 2020 Mar; 28(6):115345. PubMed ID: 32061484
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
Minh NV; Thanh NT; Lien HT; Anh DTP; Cuong HD; Nam NH; Hai PT; Minh-Ngoc L; Le-Thi-Thu H; Chinh LV; Vu TK
Anticancer Agents Med Chem; 2019; 19(12):1543-1557. PubMed ID: 31267876
[TBL] [Abstract][Full Text] [Related]
16. Novel chimeric histone deacetylase inhibitors: a series of lapatinib hybrides as potent inhibitors of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and histone deacetylase activity.
Mahboobi S; Sellmer A; Winkler M; Eichhorn E; Pongratz H; Ciossek T; Baer T; Maier T; Beckers T
J Med Chem; 2010 Dec; 53(24):8546-55. PubMed ID: 21080629
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel hydroxamates and 2-aminobenzamides as potent histone deacetylase inhibitors and antitumor agents.
Xie R; Yao Y; Tang P; Chen G; Liu X; Yun F; Cheng C; Wu X; Yuan Q
Eur J Med Chem; 2017 Jul; 134():1-12. PubMed ID: 28391133
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
Xie R; Li Y; Tang P; Yuan Q
Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
[TBL] [Abstract][Full Text] [Related]
19. A structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitors.
Guerrant W; Mwakwari SC; Chen PC; Khan SI; Tekwani BL; Oyelere AK
ChemMedChem; 2010 Aug; 5(8):1232-5. PubMed ID: 20533500
[No Abstract] [Full Text] [Related]
20. Progress in the Discovery of Macrocyclic Histone Deacetylase Inhibitors for the Treatment of Cancer.
Cheng K; Li S; Liao C
Curr Med Chem; 2017; 24(37):4166-4179. PubMed ID: 28183258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
